Comparable outcomes between immune-tolerant and active phases in noncirrhotic chronic hepatitis B: a meta-analysis

Antiviral therapy is not indicated for patients with chronic hepatitis B (CHB) in the immune-tolerant (IT) phase. We compared the outcomes between the untreated IT phase and the treated immune-active (IA) phase in noncirrhotic HBeAg-positive CHB patients. METHODS: We systematically searched 4 databa...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Han Ah, Kim, Seung Up, Seo, Yeon Seok, Ahn, Sang Hoon, Rim, Chai Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9851695/
https://www.ncbi.nlm.nih.gov/pubmed/36691962
http://dx.doi.org/10.1097/HC9.0000000000000011

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9851695/
https://www.ncbi.nlm.nih.gov/pubmed/36691962
http://dx.doi.org/10.1097/HC9.0000000000000011

Ejemplares similares